| Date | Time | Source | Headline | Symbol | Company |
| 04/04/2022 | 9:00AM | GlobeNewswire Inc. | INmune Bio, Inc. Highlights INKmune™ Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit | NASDAQ:INMB | INmune Bio Inc |
| 03/31/2022 | 5:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 03/30/2022 | 8:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 03/30/2022 | 8:00AM | GlobeNewswire Inc. | INmune Bio, Inc. Announces Company’s CSO Dr. Mark Lowdell to Co-Host the “NK Cells in Solid Tumors” Workshop at Innate Killer Summit | NASDAQ:INMB | INmune Bio Inc |
| 03/25/2022 | 4:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 03/25/2022 | 9:00AM | GlobeNewswire Inc. | INmune Bio, Inc. Spotlights Key Findings in Presentations at AD/PD™ 2022 | NASDAQ:INMB | INmune Bio Inc |
| 03/23/2022 | 4:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 03/23/2022 | 4:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 03/23/2022 | 4:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 03/23/2022 | 4:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 03/23/2022 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 03/23/2022 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 03/19/2022 | 5:09AM | TipRanks | BTIG Initiates a Buy Rating on Inmune Bio (INMB) | NASDAQ:INMB | INmune Bio Inc |
| 03/16/2022 | 4:00PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 03/15/2022 | 8:00AM | GlobeNewswire Inc. | INmune Bio, Inc. Announces Nine Data Presentations at AD/PD™ 2022 - International Conference on Alzheimer's and Parkinson's Diseases | NASDAQ:INMB | INmune Bio Inc |
| 03/14/2022 | 4:30PM | GlobeNewswire Inc. | INmune Bio, Inc. to Participate in the 32nd Annual Oppenheimer Healthcare Conference and the 2022 Maxim Group Virtual Growth Conference | NASDAQ:INMB | INmune Bio Inc |
| 03/07/2022 | 7:15PM | TipRanks | B.Riley Financial Sticks to Their Buy Rating for Inmune Bio (INMB) | NASDAQ:INMB | INmune Bio Inc |
| 03/05/2022 | 11:25AM | TipRanks | Maxim Group Thinks Inmune Bio’s Stock is Going to Recover | NASDAQ:INMB | INmune Bio Inc |
| 03/03/2022 | 4:00PM | GlobeNewswire Inc. | INmune Bio, Inc. Announces Fourth Quarter and Full Year 2021 Results and Provides Business Update | NASDAQ:INMB | INmune Bio Inc |
| 02/23/2022 | 4:36PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 02/14/2022 | 6:18AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:INMB | INmune Bio Inc |
| 02/10/2022 | 12:41PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:INMB | INmune Bio Inc |
| 01/27/2022 | 4:01PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 01/23/2022 | 11:48AM | TipRanks | Inmune Bio (INMB) Receives a Buy from B.Riley Financial | NASDAQ:INMB | INmune Bio Inc |
| 12/21/2021 | 4:05PM | Edgar (US Regulatory) | Amended Securities Registration (section 12(b)) (8-a12b/a) | NASDAQ:INMB | INmune Bio Inc |
| 12/09/2021 | 9:01AM | GlobeNewswire Inc. | INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to be Presented at the 2021 San Antonio Breast Cancer Symposium | NASDAQ:INMB | INmune Bio Inc |
| 12/01/2021 | 4:54PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INMB | INmune Bio Inc |
| 12/01/2021 | 9:00AM | GlobeNewswire Inc. | INmune Bio, Inc. Announces Two Presentations at the 2021 British Society of Immunology Congress and Provides 119-day data on First patient in MDS trial. | NASDAQ:INMB | INmune Bio Inc |
| 11/17/2021 | 6:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INMB | INmune Bio Inc |
| 11/15/2021 | 8:00AM | GlobeNewswire Inc. | CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors | NASDAQ:INMB | INmune Bio Inc |